Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: Flexibility in aphthovirus receptor usage

Journal of Virology

Volumn 74, Issue 4, 2000, Pages 1641-1647

  Baranowski, Eric ^a   Ruiz Jarabo, Carmen M ^a   Sevllla, Noemi ^a,d   Andreu, David ^b   Beck, Ewald ^c   Domingo, Esteban ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; INTEGRIN; INTEGRIN RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; HUMAN; HUMAN CELL; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; APHTHOVIRUS; BINDING SITES; CAPSID; CAPSID PROTEINS; CELL LINE; CHO CELLS; CRICETINAE; HEPARITIN SULFATE; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RECEPTORS, VIRUS; RECEPTORS, VITRONECTIN; RECOMBINATION, GENETIC; VIRUS REPLICATION;

EID: 0033931398     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.4.1641-1647.2000     Document Type: Article

References (65)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-716.
2. Bachrach, H. L. 1968. Foot-and-mouth disease virus. Annu. Rev. Microbiol. 22:201-244.
3. Baranowski, E., N. Sevilla, N. Verdaguer, C. Ruiz-Jarabo, E. Beck, and E. Domingo. 1998. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 72:6362-6372.
4. Baxt, B., and Y. Becker. 1990. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73-83.
5. Belsham, G. J. 1993. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structures. Prog. Biophys. Mol. Biol. 60:241-260.
6. 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664-2666.
7. Bittle, J. L., R. A. Houghten, H. Alexander, T. M. Shinnick, J. C. Sutcliffe, R. A. Lerner, D. J. Rowlands, and F. Brown. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30-33.
8. Borrego, B., I. S. Novella, E. Giralt, D. Andreu, and E. Domingo. 1993. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J. Virol. 67:6071-6079.
9. Brown, F. 1994. Foot-and-mouth disease, p. 416-432. In B. H. Nicholson (ed.), Synthetic vaccines. Blackwell Scientific Publications, Oxford, England.
10. Byrnes, A. P., and D. E. Griffin. 1998. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:7349-7356.
11. Carreño, C., X. Roig, J. Cairo, J. Camarero, M. G. Mateu, E. Domingo, E. Giralt, and D. Andreu. 1992. Studies on antigenic variability of C strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies. Int. J. Pept. Protein Res. 39:41-47.
12. Carrillo, C., M. Borca, D. M. Moore, D. O. Morgan, and F. Sobrino. 1998. In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J. Gen. Virol. 79:1699-1706.
13. Charpentier, N., M. Dávila, E. Domingo, and C. Escarmís. 1996. Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. Virology 223: 10-18.
14. Danen, E., S.-I. Aota, A. van Kraats, K. Yamada, D. Ruiter, and G. van Muyen. 1995. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin α5β1. J. Biol. Chem. 270: 21612-21618.
15. Domingo, E., M. Dávila, and J. Ortín. 1980. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus. Gene 11:333-346.
16. Domingo, E., C. Escarmís, L. Menédez-Arias, and J. J. Holland. 1999. Viral quasispecies and fitness variations, p. 141-161. In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, London, England.
17. Domingo, E., and J. J. Holland. 1997. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:151-178.
18. Duarte, E., D. Clarke, A. Moya, E. Domingo, and J. J. Holland. 1992. Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc. Natl. Acad. Sci. USA 89:6015-6019.
19. Eigen, M., and C. K. Biebricher. 1988. Sequence space and quasispecies distribution, p. 211-245. In E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA genetics, vol. 3. CRC Press, Inc., Boca Raton, Fla.
20. Escarmís, C., E. C. Carrillo, M. Ferrer, J. F. García Arriaza, N. López, C. Tami, N. Verdaguer, E. Domingo, and M. T. Franze-Fernández. 1998. Rapid selection in modified BHK-21 cells of foot-and-mouth disease virus variant showing altetations in cell tropism. J. Virol. 72:10171-10179.
21. Escarmís, C., M. Dávila, N. Charpentier, A. Bracho, A. Moya, and E. Domingo. 1996. Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 264:255-267.
22. Escarmís, C., M. Dávila, and E. Domingo. 1999. Multiple molecular pathways for fitness recover) of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 285:495-505.
23. Evans, D. J., and J. W. Almond. 1998. Cell receptors for picornaviruses as determinant of cell tropism and pathogenesis. Trends Microbiol. 6:198-202.
24. Fox, G., N. Parry, P. V. Barnett, B. McGlinn, D. J. Rowlands, and F. Brown. 1989. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (argine-glycine-aspartic acid). J. Gen. Virol. 70:625-637.
25. Fry, E. E., S. M. Lea, T. Jackson, J. W. Newman, F. M. Ellard, W. E. Blakemore, R. Abu-Ghazaleh, A. Samuel, A. M. King, and D. Stuart. 1999. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 18:543-554.
26. Gmyl, A. P., E. V. Pilipenko, S. V. Maslova, G. A. Belov, and V. I. Agol. 1993. Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5'-untranslated region yield a variety of pseudorevertants. J. Virol. 67:6309-6316.
27. Goudsmit, J., A. De Ronde, D. Ho, and A. S. Perelson. 1996. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70:5662-5664.
28. Gromeier, M., E. Wimmer, and A. E. Gorbalenya. 1999. Genesis, pathogenesis and evolution of picornaviruses, p. 287-343. In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, London, England.
29. Harrigan, P. R., S. Bloor, and B. A. Larder. 1998. Relative replicative fitness of zidovudine-resistant human immunodeficiency type 1 isolates in vitro. J. Virol. 72:3773-3778.
30. Hernández, J., M. L. Valero, D. Andreu, E. Domingo, and M. G. Mateu. 1996. Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif: a structural interpretation. J. Gen. Virol. 77:257-264.
31. Hewat, E. A., N. Verdaguer, I. Fita, W. Blakemore, S. Brookes, A. King, J. Newman, E. Domingo, M. G. Mateu, and D. Stuart. 1997. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. EMBO J. 16: 1492-1500.
32. Hoffman, T. L., E. B. Stephens, O. Narayan, and R. W. Doms. 1998. HIV type 1 envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc. Natl. Acad. Sci. USA 95:11360-11365.
33. Holland, J. J., J. C. de la Torre, D. K. Clarke, and E. Duarte. 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65:2960-2967.
34. Holland, J. J., J. C. de la Torre, and D. A. Steinhauer. 1992. RNA viral population as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
35. Holland, J. J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and S. Vande Pol. 1982. Rapid evolution of RNA genomes. Science 215:1577-1585.
36. Hsu, E. C., F. Sarangi, C. Iorio, M. S. Sidhu, S. A. Udem, D. L. Dillehay, W. Xu, P. A. Rota, W. J. Bellini, and C. D. Richardson. 1998. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J. Virol. 72:2905-2916.
37. Jackson, T., F. M. Ellard, R. Abu Ghazaleh, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, J. W. Newman, and A. M. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
38. 3 in vitro. J. Virol. 71:8357-8361.
39. Lea, S., J. Hernandez, W. Blakemore, E. Brocchi, S. Curry, E. Domingo, E. Fry, R. Abu-Ghazaleh, A. King, J. Newman, D. Stuart, and M. G. Mateu. 1994. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2:123-139.
40. Leippert, M., E. Beck, F. Weiland, and E. Pfaff. 1997. Point mutations within the βG-βH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. J. Virol. 71:1046-1051.
41. Logan, D., R. Abu-Ghazaleh, W. Blakemore, S. Cyrry, T. Jackson, A. King, S. Lea, R. Lewis, J. Newman, N. Parry, D. Rowlands, D. Stuart, and E. Fry. 1993. Structure of a major immunogenic site of foot-and-mouth disease virus. Nature 362:566-568.
42. Martínez, M. A., C. Carrillo, F. González-Candelas, A. Moya, E. Domingo, and F. Sobrino. 1991. Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J. Virol. 65: 3954-3957.
43. Martínez, M. A., N. Verdaguer, M. G. Mateu, and E. Domingo. 1997. Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 94:6798-6802.
44. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus in essential for infecting cells via the natural receptor but can be bypassed and antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932-1936.
45. Mateu, M. G. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38:1-24.
46. Mateu, M. G., M. A. Martínez, L. Capucci, D. Andreu, E. Giralt, F. Sobrino, E. Brocchi, and E. Domingo. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71:629-637.
47. Mateu, M. G., M. A. Martínez, E. Rocha, D. Andreu, J. Parejo, E. Giralt, F. Sobrino, and E. Domingo. 1989. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 86:5883-5887.
48. Mateu, M. G., M. L. Valero, D. Andreu, and E. Domingo. 1996. Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus: effect on cell recognition. J. Biol. Chem. 271:12814-12819.
49. McKenna, T. S. C., J. Lubroth, E. Reider, B. Baxt, and P. W. Mason. 1995. Receptor binding-site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69:5787-5790.
50. 3 as its receptor. J. Virol. 72:3587-3594.
51. Novella, I. S., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Exponential increases of RNA virus fitness during large population transmission. Proc. Natl. Acad. Sci. USA 92:5841-5844.
52. Nowak, M. A. 1992. What is a quasispecies? Trends Ecol. Evol. 7:118-121.
53. Pfaff, E., M. Mussgay, H. O. Böhm, G. E. Schultz, and H. Schaller. 1982. Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J. 1:869-874.
54. Preston, B. D., and J. P. Dougherty. 1996. Mechanisms of retroviral mutation. Trends Microbiol. 4:16-21.
55. Rueckert, R. R. 1996. Picornaviridae: the viruses and their replication, p. 609-654. In B. N. Fields et al. (ed.), Fields virology. Lippincott-Raven Publishers. Philadelphia, Pa.
56. Ruiz-Jarabo, C. M., N. Sevilla, M. Dávila, G. Gómez-Mariano, E. Baranowski, and E. Domingo. 1999. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif. J. Gen. Virol. 80:1899-1909.
57. Sá-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123.
58. Sevilla, N., and E. Domingo. 1996. Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification. J. Virol. 70:6617-6624.
59. Sobrino, F., M. Dávila, J. Ortin, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128:310-318.
60. Strohmaier, K., R. Franze, and K. H. Adam. 1982. Location and characterization of the anligenic portion of the FMDV immunizing protein. J. Gen. Virol. 59:295-306.
61. Verdaguer, N., M. G. Mateu, D. Andreu, E. Giralt, E. Domingo, and I. Fita. 1995. Structure of the major antigen loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 14:1690-1696.
62. Verdaguer, N., G. Schoehn, W. F. Ochoa, I. Fita, S. Brookes, A. King, E. Domingo, M. G. Mateu, D. Stuart, and E. A. Hewat. 1999. Flexibility of the major antigenic loop of foot-and-mouth disease virus hound to an Fab fragment of a neutralizing antibody: structure and neutralization. Virology 255:260-268.
63. Verdaguer, N., N. Sevilla, M. L. Valero, D. Stuart, E. Brocchi, D. Andreu, E. Giralt, E. Domingo, M. G. Mateu, and I. Fita. 1998. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implication for intratypic antigenic variation. J. Virol. 72:739-748.
64. Zennou, V., F. Mammano, S. Paulous, D. Mathez, and F. Clavel. 1998. Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo. J. Virol. 72:3300-3306.
65. Zibert, A., G. Maass, K. Strebel, M. M. Falk, and E. Beck. 1990. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J. Virol. 64:2467-2473.